Search

  • HOME
  • Search
Original Article
1622
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Clin Mol Hepatol. 2021;27(4):575-588.   Published online July 13, 2021
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol. 2020;26(1):60-69.   Published online October 22, 2019
Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Shinya Sato, Kei Moriya, Masanori Furukawa, Soichiro Saikawa, Tadashi Namisaki, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol. 2019;25(1):65-73.   Published online February 25, 2019
1411
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Clin Mol Hepatol. 2018;24(3):311-318.   Published online June 4, 2018
Case Report
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol. 2016;22(3):390-395.   Published online August 30, 2016
Original Article
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim
Clin Mol Hepatol. 2015;21(2):125-130.   Published online June 26, 2015
Original Article
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh
Clin Mol Hepatol. 2013;19(1):60-69.   Published online March 25, 2013
Original Article
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clin Mol Hepatol. 2012;18(4):360-367.   Published online December 21, 2012
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clin Mol Hepatol. 2012;18(3):272-278.   Published online September 25, 2012
Original Article
Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients
Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang
Clin Mol Hepatol. 2012;18(1):41-47.   Published online March 22, 2012
Review
Recent trends in the treatment of chronic hepatitis C
Dae Won Jun, Won Young Tak, Si Hyun Bae, Youn Jae Lee
Clin Mol Hepatol. 2012;18(1):22-28.   Published online March 22, 2012
Original Article
Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
Kyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suh
Clin Mol Hepatol. 2011;17(3):220-225.   Published online September 30, 2011
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
Clin Mol Hepatol. 2011;17(3):183-188.   Published online September 30, 2011
3
Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D., Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.
Clin Mol Hepatol. 2010;16(1):38-48.   Published online March 26, 2010
A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C
Mi Na Kim, M.D. Ki Tae Yoon, M.D. Jun Yong Park, M.D. Do Young Kim, M.D. Sang Hoon Ahn, M.D. Chae Yoon Chon, M.D. Kwang-Hyub Han, M.D.
Clin Mol Hepatol. 2009;15(4):496-503.   Published online December 31, 2009
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
Soung Won Jeong, M.D., Jin Dong Kim, M.D. Hyun Young Woo, M.D. Chan Ran You, M.D. Sung Won Lee, M.D. Myeong Jun Song, M.D. Jung Won Jang, M.D. Si Hyun Bae, M.D. Jong Young Choi, M.D. Seung Kew Yoon, M.D.
Clin Mol Hepatol. 2009;15(3):338-349.   Published online September 30, 2009
Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
Chul Hyun Kim , Byung Do Park , Jin Woo Lee , Young Soo Kim , Seok Jeong , Don Haeng Lee , Hyung Gil Kim , Yong Woon Shin , Key Sook Kwon , Jung Il Lee
Clin Mol Hepatol. 2009;15(1):70-79.   Published online March 31, 2009
Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients Living in Daejeon and Chungcheong Province in Korea: A comparative study
Jeong Il Kim, M.D, Seok Hyun Kim, M.D., Byung Seok Lee, M.D., Heon Young Lee, M.D., Tae Hee Lee, M.D. Young Woo Kang, M.D. Hyang Ie Lee, M.D. An Na Kim, M.D. Soon Woo Nam, M.D. Byeong Chool Park, M.D. Hee Bok Chae, M.D. Seok Bae Kim, M.D. Il Han Song, M.D. Ji Young Park, M.D. Hong Su Kim, M.D.
Clin Mol Hepatol. 2008;14(4):493-502.   Published online December 31, 2008
3
Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
Myoung Joo Kang, M.D., Eun Uk Jung, M.D., Sang Won Park, M.D., Paul Choi, M.D., Ji Hyun Kim, M.D., Sung Jae Park, M.D., Eun Taek Park, M.D., Youn Jae Lee, M.D., Sang Hyuk Lee, M.D., Sang Yong Seol, M.D.
Clin Mol Hepatol. 2008;14(3):318-330.   Published online September 30, 2008
Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
Kyoung Tae Kim , Sang Young Han , Jong Han Kim , Hyun Ah Yoon , Yang Hyun Baek , Min Ji Kim , Sung Wook Lee , Jin Seok Jang , Jong Hun Lee , Myung Hwan Roh
Clin Mol Hepatol. 2008;14(1):36-45.   Published online March 20, 2008
Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients
Eun Uk Jung , Ji Hun Park , Kyung Im Pae , Suk Woo Kang , Sung Jae Park , Sam Ryong Jee , Eun Tak Park , Youn Jae Lee , Sang Hyuk Lee , Sang Young Seol
Clin Mol Hepatol. 2007;13(3):341-348.   Published online September 20, 2007
1
Treatment of Chronic Hepatitis C: Shorter Treatment Duration For Genotype 2 or 3 Infection
Sook Hyang Jeong
Clin Mol Hepatol. 2007;13(3):301-303.   Published online September 20, 2007
3
Peginterferon Alfa-2a plus Ribavirin for Initial Treatment of Chronic Hepatitis C in Korea
Hyuk Lee, M.D., Moon Seok Choi, M.D., Seung Woon Paik, M.D., Jeong Hwan Kim, M.D., Do Young Kim, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Soon Mi Song, R.N.
Clin Mol Hepatol. 2006;12(1):31-40.   Published online January 1, 1970
2
Peginterferon-alpha and Ribavirin Combination Therapy in Chronic Hepatitis C
Kwang Hyub Han , Young Hoon Yoon
Clin Mol Hepatol. 2004;10(2):81-87.   Published online January 1, 1970
1 | 2 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 582
TOTAL : 652499
Close layer